8095.T
Astena Holdings Co., Ltd. [8095.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8095.T Stock Summary
Top 10 Correlated ETFs
8095.T
Top 10 Correlated Stocks
8095.T
In the News
8095.T Financial details
Company Rating
Buy
Market Cap
19.01B
Income
1.15B
Revenue
51.98B
Book val./share
719.51
Cash/share
174.21
Dividend
18
Dividend %
3.72%
Employees
1.4K
Optionable
No
Shortable
Yes
Earnings
11 Apr 2024
P/E
109.03
Forward P/E
-
PEG
10.83
P/S
0.36
P/B
0.71
P/C
2.75
P/FCF
-
Quick Ratio
0.7
Current Ratio
1.2
Debt / Equity
0.59
LT Debt / Equity
0.16
-
-
EPS (TTM)
29.22
EPS next Y
-
EPS next Q
-
EPS this Y
102.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.92%
Revenue last 5Y
-3.35%
Revenue Q/Q
-18.15%
EPS Q/Q
117.69%
-
-
-
-
SMA20
1.68%
SMA50
1.68%
SMA100
-4.9%
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
0.03%
Gross Margin
30%
Oper. Margin
2%
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
421.0-548.0
52W High
-12.59%
52W Low
+13.78%
RSI
47
Rel Volume
1.61
Avg Volume
71.55K
Volume
115.4K
Perf Week
-0.62%
Perf Month
1.05%
Perf Quarter
-9.28%
Perf Half Y
-5.34%
-
-
-
-
Beta
0.128
-
-
Volatility
5.57%, 5.6%
Prev Close
-1.64%
Price
479
Change
-2.04%
8095.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-11-30
| Metric | History | 2019-11-30 | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.89K | 1.99K | 1.95K | 1.25K | 1.32K | |
| Net income per share | 47.01 | 60.33 | 46.86 | 14.56 | 29.47 | |
| Operating cash flow per share | 49.17 | 126.02 | 36.4 | -18.65 | 41.66 | |
| Free cash flow per share | 3.33 | 72.7 | -57.87 | -94.76 | -63.89 | |
| Cash per share | 144.88 | 222.83 | 279.48 | 177.02 | 174.38 | |
| Book value per share | 626.19 | 658.48 | 728.48 | 677.83 | 720.21 | |
| Tangible book value per share | 581.61 | 431.36 | 501.69 | 471.79 | 535.79 | |
| Share holders equity per share | 626.19 | 658.48 | 728.48 | 677.83 | 720.21 | |
| Interest debt per share | 153.17 | 371.62 | 409.93 | 378.47 | 428.76 | |
| Market cap | 15.43B | 17.3B | 18.01B | 16.6B | 19.61B | |
| Enterprise value | 15.48B | 21.9B | 22.22B | 24.69B | 29.85B | |
| P/E ratio | 10.06 | 8.72 | 10.37 | 28.64 | 16.87 | |
| Price to sales ratio | 0.25 | 0.26 | 0.25 | 0.33 | 0.38 | |
| POCF ratio | 9.62 | 4.17 | 13.35 | -22.36 | 11.93 | |
| PFCF ratio | 141.89 | 7.24 | -8.4 | -4.4 | -7.78 | |
| P/B Ratio | 0.76 | 0.8 | 0.67 | 0.62 | 0.69 | |
| PTB ratio | 0.76 | 0.8 | 0.67 | 0.62 | 0.69 | |
| EV to sales | 0.25 | 0.34 | 0.31 | 0.5 | 0.57 | |
| Enterprise value over EBITDA | 5 | 6.55 | 5.19 | 8.23 | 8.14 | |
| EV to operating cash flow | 9.66 | 5.29 | 16.47 | -33.26 | 18.16 | |
| EV to free cash flow | 142.42 | 9.16 | -10.36 | -6.54 | -11.84 | |
| Earnings yield | 0.1 | 0.11 | 0.1 | 0.03 | 0.06 | |
| Free cash flow yield | 0.01 | 0.14 | -0.12 | -0.23 | -0.13 | |
| Debt to equity | 0.24 | 0.56 | 0.56 | 0.56 | 0.59 | |
| Debt to assets | 0.11 | 0.22 | 0.24 | 0.24 | 0.25 | |
| Net debt to EBITDA | 0.02 | 1.38 | 0.98 | 2.7 | 2.79 | |
| Current ratio | 1.46 | 1.39 | 1.43 | 1.32 | 1.26 | |
| Interest coverage | 92.13 | 43.06 | 37.34 | 15.6 | 15.27 | |
| Income quality | 0.7 | 1.6 | 0.44 | -0.52 | 1.41 | |
| Dividend Yield | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | |
| Payout ratio | 0.25 | 0.24 | 0.37 | 1.26 | 0.62 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.03 | 0.14 | 0.13 | 0.13 | 0.11 | |
| Capex to operating cash flow | -0.93 | -0.42 | -2.59 | 4.08 | -2.53 | |
| Capex to revenue | -0.02 | -0.03 | -0.05 | -0.06 | -0.08 | |
| Capex to depreciation | -1.83 | -1.28 | -1.91 | -1.43 | -1.64 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 813.88 | 945.45 | 876.44 | 471.2 | 691 | |
| ROIC | 0.06 | 0.05 | 0.03 | 0.01 | 0.02 | |
| Return on tangible assets | 0.04 | 0.04 | 0.03 | 0.01 | 0.02 | |
| Graham Net | -130.56 | -344.67 | -292.58 | -317.63 | -296.63 | |
| Working capital | 9.53B | 8.95B | 11.42B | 8.96B | 7.91B | |
| Tangible asset value | 18.97B | 14.18B | 18.59B | 18.78B | 21.14B | |
| Net current asset value | 6.09B | -791.55M | 1.51B | 266.41M | -759.17M | |
| Invested capital | 0.24 | 0.56 | 0.56 | 0.56 | 0.59 | |
| Average receivables | 15.66B | 14.52B | 13.67B | 15.15B | 17.81B | |
| Average payables | 9.65B | 8.94B | 8.52B | 8.66B | 10.27B | |
| Average inventory | 6.23B | 7.53B | 8.85B | 9.41B | 10.14B | |
| Days sales outstanding | 94.38 | 73.17 | 71.84 | 118.09 | 137.32 | |
| Days payables outstanding | 73.4 | 58.71 | 57.99 | 90.46 | 119.71 | |
| Days of inventory on hand | 50.6 | 60.06 | 61.17 | 101.29 | 107.04 | |
| Receivables turnover | 3.87 | 4.99 | 5.08 | 3.09 | 2.66 | |
| Payables turnover | 4.97 | 6.22 | 6.29 | 4.03 | 3.05 | |
| Inventory turnover | 7.21 | 6.08 | 5.97 | 3.6 | 3.41 | |
| ROE | 0.08 | 0.09 | 0.06 | 0.02 | 0.04 | |
| Capex per share | -45.83 | -53.32 | -94.28 | -76.12 | -105.55 |
Quarterly Fundamentals Overview
Last date of statement is 2023-11-30 for Q4
| Metric | History | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 | 2023-11-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 321.95 | 324.69 | 356.25 | 349.8 | 286.33 | |
| Net income per share | -0.68 | -5.28 | -0.7 | 11.08 | 24.12 | |
| Operating cash flow per share | 43.18 | 27.2 | 31.71 | 28.44 | 29.05 | |
| Free cash flow per share | 43.18 | 27.2 | 31.71 | 28.44 | 29.05 | |
| Cash per share | 178.55 | 171.61 | 140.53 | 157.08 | 174.21 | |
| Book value per share | 683.7 | 670.52 | 671.4 | 685.9 | 719.51 | |
| Tangible book value per share | 475.88 | 461.38 | 468.75 | 485.3 | 535.27 | |
| Share holders equity per share | 683.7 | 670.52 | 671.4 | 685.9 | 719.51 | |
| Interest debt per share | 380.73 | 402.86 | 405.24 | 471.78 | 427.2 | |
| Market cap | 16.46B | 16.85B | 16.99B | 18.05B | 19.63B | |
| Enterprise value | 24.55B | 25.94B | 27.55B | 30.47B | 29.86B | |
| P/E ratio | -154.09 | -20.27 | -152.8 | 10.31 | 5.15 | |
| Price to sales ratio | 1.3 | 1.32 | 1.21 | 1.31 | 1.74 | |
| POCF ratio | 9.66 | 15.74 | 13.56 | 16.07 | 17.11 | |
| PFCF ratio | 9.66 | 15.74 | 13.56 | 16.07 | 17.11 | |
| P/B Ratio | 0.61 | 0.64 | 0.64 | 0.67 | 0.69 | |
| PTB ratio | 0.61 | 0.64 | 0.64 | 0.67 | 0.69 | |
| EV to sales | 1.93 | 2.03 | 1.96 | 2.2 | 2.64 | |
| Enterprise value over EBITDA | 75.2 | -536.95 | 76.25 | 58.34 | 22.32 | |
| EV to operating cash flow | 14.4 | 24.23 | 22 | 27.12 | 26.03 | |
| EV to free cash flow | 14.4 | 24.23 | 22 | 27.12 | 26.03 | |
| Earnings yield | 0 | -0.01 | 0 | 0.02 | 0.05 | |
| Free cash flow yield | 0.1 | 0.06 | 0.07 | 0.06 | 0.06 | |
| Debt to equity | 0.56 | 0.6 | 0.6 | 0.69 | 0.59 | |
| Debt to assets | 0.24 | 0.25 | 0.25 | 0.28 | 0.25 | |
| Net debt to EBITDA | 24.78 | -188.15 | 29.24 | 23.77 | 7.65 | |
| Current ratio | 1.32 | 1.31 | 1.23 | 1.2 | 1.26 | |
| Interest coverage | 31.49 | -6.17 | 20.64 | 30.37 | 15.42 | |
| Income quality | -63.13 | -5.2 | -59.64 | 2.58 | 1.2 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.13 | 0.13 | 0.13 | 0.12 | 0.11 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 102.02 | 282.21 | 103.09 | 413.52 | 624.93 | |
| ROIC | 0 | -0.01 | 0 | 0.01 | 0.01 | |
| Return on tangible assets | 0 | 0 | 0 | 0.01 | 0.02 | |
| Graham Net | -320.38 | -364.26 | -413.45 | -421.31 | -296.34 | |
| Working capital | 8.96B | 8.75B | 6.81B | 6.34B | 7.91B | |
| Tangible asset value | 18.78B | 18.17B | 18.52B | 19.17B | 21.14B | |
| Net current asset value | 266.41M | -429.84M | -2.11B | -2.32B | -759.17M | |
| Invested capital | 0.56 | 0.6 | 0.6 | 0.69 | 0.59 | |
| Average receivables | 15.25B | 15.26B | 14.76B | 15.37B | 17.61B | |
| Average payables | 8.45B | 8.89B | 9.1B | 8.84B | 10.43B | |
| Average inventory | 9.7B | 9.88B | 10.16B | 10.34B | 10.72B | |
| Days sales outstanding | 113.74 | 101.78 | 96.38 | 102.05 | 155.64 | |
| Days payables outstanding | 85.33 | 91.1 | 81.63 | 82.14 | 154.44 | |
| Days of inventory on hand | 95.54 | 100.54 | 92.06 | 99.48 | 138.1 | |
| Receivables turnover | 0.79 | 0.88 | 0.93 | 0.88 | 0.58 | |
| Payables turnover | 1.05 | 0.99 | 1.1 | 1.1 | 0.58 | |
| Inventory turnover | 0.94 | 0.9 | 0.98 | 0.9 | 0.65 | |
| ROE | 0 | -0.01 | 0 | 0.02 | 0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
8095.T Frequently Asked Questions
What is Astena Holdings Co., Ltd. stock symbol ?
Astena Holdings Co., Ltd. is a JP stock and trading under the symbol 8095.T
What is Astena Holdings Co., Ltd. stock quote today ?
Astena Holdings Co., Ltd. stock price is $479 today.
Is Astena Holdings Co., Ltd. stock public?
Yes, Astena Holdings Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 71.55K
- Market Capitalization 19.01B
- Employee 1.4K
- CEO Mr. Satoshi Setoguchi
- Headquarters Chuo,JP
- IPO Date 2001-01-01
-
Website
https://www.astena-hd.com 
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
